Three of the UK’s leading neurological research charities have joined forces to launch a new challenge event this autumn.
The Brainathlon Half is a fun, family-friendly relay challenge and is a collaboration between Brain Research UK (based in Coty of London), Brain Tumour Research (based in Milton Keynes), and Epilepsy Research UK. It will raise vital funds to support research, improve outcomes and help people affected by neurological conditions, including brain tumours and epilepsy.
Participants are being invited to compete on their own or as part of a team to walk 5 miles, run 7.5 miles and climb 0.6 miles (by walking up 1,250 stairs or equivalent) to complete the 13.1 miles of the challenge during Brainathlon Half Week (Monday 25 to Sunday 31 October). Finishers will receive a specially commissioned medal, knowing the money they raise will be distributed equally between the three charities.
Sue Farrington Smith MBE, chief executive of Brain Tumour Research, said:
We are pleased to be collaborating once again with Epilepsy Research UK and Brain Research UK to bring hope to the many thousands of people living with neurological conditions and to honour the memory of those who have died.
Brainathlon represented a great opportunity to show that together we can be stronger and to give people the experience of competing in a marathon. We’re pleased to be building on its success and launching the Brainathlon Half, offering all the family the opportunity to get involved.
Funds raised will be split equally between the three charities to improve treatments and outcomes for people with a neurological condition, including brain tumours and epilepsy.
The charities are running Brainathlon Half through the Realbuzz events platformand participants are given a week to complete the challenge. Those taking part as individuals are asked to raise a minimum sponsorship of £100 or £300 if taking part as a team of three.
Registrations are open and information can be found at https://brainathlon.realbuzzevents.com/en/
Image credit: Brain Tumour Research